FRANKLIN M BERGER Insider Trading Transactions
Get free email notifications about insider trading for FRANKLIN M BERGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANKLIN M BERGER. FRANKLIN M BERGER is Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in Tocagen Inc ($TOCA) and Director in Immune Design Corp. ($IMDZ) and Director in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and Director in Atreca, Inc. ($BCEL) and Director in Atea Pharmaceuticals, Inc. ($AVIR) and Director in ESSA Pharma Inc. ($EPIX) and Director in Kezar Life Sciences, Inc. ($KZR) and Director in Rain Therapeutics Inc. ($RAIN).
Latest Insider Trading Transactions of FRANKLIN M BERGER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVIR, BCEL, EPIX, FPRX, TOCA, IMDZ, KZR, RAIN, YMTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 27 2021 | RAIN | Rain Therapeutics ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 578,397 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 189,998 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 535,601 | 0 | 836,540 | 300.9 K to 836.5 K (+177.98 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 175,939 | 0 | 300,939 | 125 K to 300.9 K (+140.75 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BERGER FRANKLIN M | Director | Buy | P | 15.78 | 5,000 | 78,900 | 125,000 | 120 K to 125 K (+4.17 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BERGER FRANKLIN M | Director | Buy | P | 17.00 | 120,000 | 2,040,000 | 120,000 | 0 to 120 K |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | D | 22.15 | 12,500 | 276,875 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Sell | D | 38.00 | 5,000 | 190,000 | 0 | 5 K to 0 (-100.00 %) |
Mar 04 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | P | 27.00 | 57,000 | 1,539,000 | 957,244 | 900.2 K to 957.2 K (+6.33 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | A | 7.00 | 16,500 | 115,500 | 16,500 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | A | 7.00 | 16,500 | 115,500 | 16,500 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 4.67 | 6,773 | 31,630 | 18,227 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 4.67 | 6,773 | 31,630 | 18,227 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 3.23 | 25,000 | 80,750 | 0 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 3.23 | 25,000 | 80,750 | 0 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 3.81 | 2,184 | 8,321 | 2,816 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 3.81 | 2,184 | 8,321 | 2,816 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 4.00 | 6,534 | 26,136 | 2,966 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 4.00 | 6,534 | 26,136 | 2,966 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 4.00 | 1,716 | 6,864 | 784 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Option Exercise | M | 4.00 | 1,716 | 6,864 | 784 | |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 4.67 | 6,773 | 31,630 | 900,244 | 893.5 K to 900.2 K (+0.76 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 4.67 | 6,773 | 31,630 | 900,244 | 893.5 K to 900.2 K (+0.76 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 3.23 | 25,000 | 80,750 | 893,471 | 868.5 K to 893.5 K (+2.88 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 3.23 | 25,000 | 80,750 | 893,471 | 868.5 K to 893.5 K (+2.88 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 3.81 | 2,184 | 8,321 | 868,471 | 866.3 K to 868.5 K (+0.25 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 3.81 | 2,184 | 8,321 | 868,471 | 866.3 K to 868.5 K (+0.25 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 4.00 | 6,534 | 26,136 | 866,287 | 859.8 K to 866.3 K (+0.76 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 4.00 | 6,534 | 26,136 | 866,287 | 859.8 K to 866.3 K (+0.76 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 4.00 | 1,716 | 6,864 | 859,753 | 858 K to 859.8 K (+0.20 %) |
Jan 11 2021 | EPIX | ESSA Pharma Inc. | BERGER FRANKLIN M | Director | Buy | M | 4.00 | 1,716 | 6,864 | 859,753 | 858 K to 859.8 K (+0.20 %) |
Oct 30 2020 | AVIR | Atea Pharmaceutica ... | BERGER FRANKLIN M | Director | Option Exercise | A | 24.00 | 80,000 | 1,920,000 | 80,000 | |
Oct 30 2020 | AVIR | Atea Pharmaceutica ... | BERGER FRANKLIN M | Director | Option Exercise | A | 24.00 | 80,000 | 1,920,000 | 80,000 | |
Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 | |
Jun 26 2020 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
Jun 15 2020 | BCEL | Atreca, Inc. | BERGER FRANKLIN M | Director | Option Exercise | A | 17.87 | 12,000 | 214,440 | 12,000 | |
Jun 11 2020 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | P | 5.50 | 100,000 | 550,000 | 784,003 | 684 K to 784 K (+14.62 %) |
May 15 2020 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
Feb 05 2020 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | P | 2.60 | 120,846 | 314,200 | 684,003 | 563.2 K to 684 K (+21.46 %) |
Dec 04 2019 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Sell | S | 4.00 | 47,890 | 191,560 | 5,000 | 52.9 K to 5 K (-90.55 %) |
Dec 04 2019 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Sell | S | 3.92 | 32,090 | 125,793 | 52,890 | 85 K to 52.9 K (-37.76 %) |
Oct 04 2019 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
Oct 04 2019 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
Jul 01 2019 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 0.94 | 15,300 | 14,382 | 15,300 | |
Jun 27 2019 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | A | 7.63 | 8,896 | 67,876 | 8,896 | |
Jun 24 2019 | BCEL | Atreca, Inc. | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 13,164 | 0 | 0 | |
Jun 24 2019 | BCEL | Atreca, Inc. | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 26,115 | 0 | 0 | |
Jun 24 2019 | BCEL | Atreca, Inc. | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 36,036 | 0 | 0 | |
Jun 24 2019 | BCEL | Atreca, Inc. | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 75,315 | 0 | 97,808 | 22.5 K to 97.8 K (+334.84 %) |
Jun 12 2019 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 6.09 | 15,000 | 91,350 | 15,000 | |
May 31 2019 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 4.22 | 20,000 | 84,400 | 20,000 | |
Apr 04 2019 | IMDZ | IMMUNE DESIGN CORP ... | BERGER FRANKLIN M | Director | Option Exercise | D | 1.31 | 12,500 | 16,375 | 0 | |
Apr 04 2019 | IMDZ | IMMUNE DESIGN CORP ... | BERGER FRANKLIN M | Director | Option Exercise | D | 4.05 | 12,500 | 50,625 | 0 | |
Apr 04 2019 | IMDZ | IMMUNE DESIGN CORP ... | BERGER FRANKLIN M | Director | Option Exercise | D | 5.60 | 10,000 | 56,000 | 0 | |
Apr 04 2019 | IMDZ | IMMUNE DESIGN CORP ... | BERGER FRANKLIN M | Director | Sell | D | 5.85 | 75,000 | 438,750 | 0 | 75 K to 0 (-100.00 %) |
Jan 07 2019 | IMDZ | IMMUNE DESIGN CORP ... | BERGER FRANKLIN M | Director | Option Exercise | A | 1.31 | 12,500 | 16,375 | 12,500 | |
Oct 26 2018 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 6.75 | 40,000 | 270,000 | 40,000 | 0 to 40 K |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 197,076 | 0 | 0 | |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 262,907 | 0 | 0 | |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | P | 15.00 | 50,000 | 750,000 | 563,157 | 513.2 K to 563.2 K (+9.74 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 197,076 | 0 | 513,157 | 316.1 K to 513.2 K (+62.35 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 262,907 | 0 | 316,081 | 53.2 K to 316.1 K (+494.43 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 197,076 | 0 | 0 | |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 262,907 | 0 | 0 | |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | P | 15.00 | 50,000 | 750,000 | 563,157 | 513.2 K to 563.2 K (+9.74 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 197,076 | 0 | 513,157 | 316.1 K to 513.2 K (+62.35 %) |
Jun 27 2018 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 262,907 | 0 | 316,081 | 53.2 K to 316.1 K (+494.43 %) |
Jun 25 2018 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 8.98 | 20,000 | 179,600 | 20,000 | |
Jun 19 2018 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 3.19 | 15,300 | 48,807 | 15,300 | |
May 14 2018 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 17.27 | 10,000 | 172,700 | 10,000 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Option Exercise | A | 4.05 | 12,500 | 50,625 | 12,500 | |
Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 5.00 | 60,000 | 300,000 | 266,162 | 206.2 K to 266.2 K (+29.10 %) |
Nov 01 2017 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Buy | P | 4.58 | 25,000 | 114,375 | 75,000 | 50 K to 75 K (+50.00 %) |
Oct 26 2017 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Buy | P | 4.26 | 25,000 | 106,620 | 50,000 | 25 K to 50 K (+100.00 %) |
Aug 07 2017 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 2.20 | 63,663 | 140,059 | 63,663 | |
May 12 2017 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
Apr 21 2017 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Buy | J | 10.00 | 25,335 | 253,350 | 25,335 | 0 to 25.3 K |
Apr 12 2017 | TOCA | Tocagen Inc | BERGER FRANKLIN M | Director | Option Exercise | A | 10.00 | 7,246 | 72,460 | 7,246 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Dec 20 2016 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Sell | S | 6.55 | 50,000 | 327,330 | 25,000 | 75 K to 25 K (-66.67 %) |
Dec 19 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 11.52 | 14,000 | 161,342 | 206,162 | 192.2 K to 206.2 K (+7.29 %) |
Dec 19 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 10.99 | 26,000 | 285,626 | 192,162 | 166.2 K to 192.2 K (+15.65 %) |
Sep 15 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 13.00 | 69,230 | 899,990 | 166,162 | 96.9 K to 166.2 K (+71.42 %) |
May 23 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | C | 0.00 | 777,604 | 0 | 0 | |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | P | 8.00 | 25,000 | 200,000 | 96,932 | 71.9 K to 96.9 K (+34.76 %) |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Buy | C | 0.00 | 71,932 | 0 | 71,932 | 0 to 71.9 K |
Feb 12 2016 | PTI | PROTEOSTASIS THERA ... | BERGER FRANKLIN M | Director | Option Exercise | A | 8.00 | 45,760 | 366,080 | 45,760 | |
Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 49.18 | 3,000 | 147,540 | 84,980 | 82 K to 85 K (+3.66 %) |
Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 49.90 | 2,000 | 99,800 | 81,980 | 80 K to 82 K (+2.50 %) |
Apr 21 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 46.74 | 2,090 | 97,687 | 79,980 | 77.9 K to 80 K (+2.68 %) |
Apr 21 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 47.23 | 4,000 | 188,920 | 77,890 | 73.9 K to 77.9 K (+5.41 %) |
Jan 06 2016 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Sep 24 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 12.70 | 12,500 | 158,750 | 0 | |
Sep 24 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 12.70 | 12,500 | 158,750 | 73,890 | 61.4 K to 73.9 K (+20.36 %) |
Sep 04 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 7.26 | 4,065 | 29,512 | 0 | |
Sep 04 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 8.49 | 4,065 | 34,512 | 0 | |
Sep 04 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 7.26 | 4,065 | 29,512 | 61,390 | 57.3 K to 61.4 K (+7.09 %) |
Sep 04 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 8.49 | 4,065 | 34,512 | 57,325 | 53.3 K to 57.3 K (+7.63 %) |
Jul 02 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 6.89 | 2,439 | 16,805 | 0 | |
Jul 02 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 5.54 | 4,065 | 22,520 | 0 | |
Jul 02 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 6.89 | 2,439 | 16,805 | 53,260 | 50.8 K to 53.3 K (+4.80 %) |
Jul 02 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 5.54 | 4,065 | 22,520 | 50,821 | 46.8 K to 50.8 K (+8.69 %) |
Jun 19 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 6.89 | 9,756 | 67,219 | 0 | |
Jun 19 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 6.89 | 9,756 | 67,219 | 46,756 | 37 K to 46.8 K (+26.37 %) |
Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
Apr 21 2015 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Buy | P | 26.50 | 25,000 | 662,500 | 75,000 | 50 K to 75 K (+50.00 %) |
Page: 1